FX Life Sciences AG
Records under this name other than patents FX Life Sciences AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,593,340 | Pharmaceutical Compositions Containing N-Propargylphentermine and Related Analogs to Treat Neurodegeneration And/Or Depression Term ended Term ended Feb 28, 2021 · High confidence | Term ended | Term ended Feb 28, 2021 | High confidence |
| US 7,906,150 | Preparation Derived from Shark Cartilage for Treatment of Diseases Related to Excessive PHF or Excessive Intracellular Calcium Term ended Term ended Dec 25, 2020 · Medium confidence | Term ended | Term ended Dec 25, 2020 | Medium confidence |
| US 6,432,454 | Processes of making north american ginseng fractions, products containing them, and use as immunomodulators Term ended Term ended Jul 27, 2020 · From the USPTO record | Term ended | Term ended Jul 27, 2020 | From the USPTO record |
| US 7,186,423 | Processes of Making North American Ginseng Fractions, Products Containing Them, and Uses as Immunomodulators Term ended Ended no later than Feb 6, 2020 · Low confidence | Term ended | Ended no later than Feb 6, 2020 | Low confidence |
| US 7,413,756 | Processes of Making North American Ginseng Fractions, Products Containing Them, and Use as Immunomodulators Term ended Term ended Dec 13, 2019 · Medium confidence | Term ended | Term ended Dec 13, 2019 | Medium confidence |
| US 8,039,027 | Treatment of autoimmune diseases with American ginseng extract Lapsed on the fee record Ended Oct 18, 2019 · From the USPTO record | Lapsed on the fee record | Ended Oct 18, 2019 | From the USPTO record |
| US 7,195,783 | Hypericin and hypericum extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics Term ended Term ended Jul 9, 2019 · From the USPTO record | Term ended | Term ended Jul 9, 2019 | From the USPTO record |
| US 7,067,160 | Processes of Making North American Ginseng Fractions, Products Containing Them, and Use as Immunomodulators Term ended Term ended Jun 28, 2019 · Medium confidence | Term ended | Term ended Jun 28, 2019 | Medium confidence |
| US 7,763,290 | Processes of making north american ginseng fractions, products containing them, and use as immunomodulators Term ended Term ended Mar 31, 2019 · From the USPTO record | Term ended | Term ended Mar 31, 2019 | From the USPTO record |
| US 7,358,342 | Preparation Derived from Shark Cartilage for Treatment of Diseased Related to Excessive PHF or Excessive Intracellular Calcium Term ended Term ended Oct 13, 2018 · Medium confidence | Term ended | Term ended Oct 13, 2018 | Medium confidence |